Birchview Capital, LP’s Relmada Therapeutics Inc Position
Does Birchview Capital, LP own Relmada Therapeutics Inc (RLMD)? Yes — 409.4K shares worth $3M (+1.62% of its 13F portfolio) as of Q1 2026.
Position Value
$3M
Q1 2026
Shares
409.4K
% of Portfolio
+1.62%
Quarters Held
1
currently held
Position History RLMD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 409.4K | $3M | +1.62% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of RLMD.